EDITORIAL
Published on 13 Jun 2023
Editorial: Subclassification of AUS/FLUS category for thyroid nodules: trials and evidence-based clinical management
doi 10.3389/fendo.2023.1209776
- 2,307 views
- Frontiers in Endocrinology
- Thyroid Endocrinology
- Research Topics
- Subclassification of AUS/FLUS Category for Thyroid Nodules: Trials and Evidence-Based Clinical Management
Subclassification of AUS/FLUS Category for Thyroid Nodules: Trials and Evidence-Based Clinical Management
3,479
Total downloads
35k
Total views and downloads
Articles
CORRECTION
Published on 18 May 2022
Corrigendum: The Risk Stratification of Papillary Thyroid Cancer With Bethesda Category III (Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance) by Thyroid Fine‐Needle Aspiration Could Be Assisted by Tumor Size for Precision Treatment
doi 10.3389/fendo.2022.911963
- 798 views
ORIGINAL RESEARCH
Published on 16 Feb 2022
Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III
doi 10.3389/fendo.2022.806028
- 13,381 views
- 10 citations
ORIGINAL RESEARCH
Published on 07 Feb 2022
The Risk Stratification of Papillary Thyroid Cancer With Bethesda Category III (Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance) by Thyroid Fine‐Needle Aspiration Could Be Assisted by Tumor Size for Precision Treatment
doi 10.3389/fendo.2022.822423
- 14,077 views
- 2 citations
ORIGINAL RESEARCH
Published on 30 Sep 2021
Malignancy Rate of Bethesda Class III Thyroid Nodules Based on the Presence of Chronic Lymphocytic Thyroiditis in Surgical Patients
doi 10.3389/fendo.2021.745395
- 3,961 views
- 6 citations
